Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medipharm Labs Corp
(OP:
MEDIF
)
0.0528
-0.0012 (-2.22%)
Streaming Delayed Price
Updated: 2:04 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medipharm Labs Corp
< Previous
1
2
3
4
5
Next >
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
↗
August 15, 2022
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) Q2 2022 revenue declined 14%, to CA$4.36 million ($3,37 million), compared to revenue of CA$5.07 million in Q2 2021.
Via
Benzinga
The Canadian Cannabis Report - Monday, Aug. 1
↗
August 01, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
MediPharm Labs Awarded Payment Of $9.8M By Ontario Court Of Justice
↗
July 27, 2022
MediPharm Labs Corp.
Via
Benzinga
The Canadian Cannabis Report - Monday, July 25
↗
July 25, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
↗
July 11, 2022
MediPharm Labs Corp.
Via
Benzinga
The Canadian Cannabis Report - Monday, June 20
↗
June 20, 2022
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
BREAKING: Brazil Supreme Court Authorizes Citizens To Grow Medicinal Cannabis
↗
June 14, 2022
What Happened?
Via
Benzinga
The Canadian Cannabis Report- Monday, May 23
↗
May 23, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
The Canadian Cannabis Report - Monday, May 16
↗
May 16, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
MediPharm Labs Q1 Revenue Slightly Drops, Here Are The Details
↗
May 16, 2022
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) revenue decreased 11.24% to $4.88 million in Q1 2022 compared to $5.5 million in Q1 2021.
Via
Benzinga
The Canadian Cannabis Report - Monday, May 9
↗
May 09, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
Cannabis Movers & Shakers: SuperNet, MediPharm, Le-Vel, Jupiter Wellness, Leafly, Acreage
↗
April 22, 2022
SuperNet Names John Pfisterer As CFO SuperNet, a payment network that enables credit card payments for cannabis merchants and consumers, has tapped John Pfisterer to oversee its financial department.
Via
Benzinga
MediPharm Labs Launches CBG And Water-Soluble CBN:THC Products
↗
April 05, 2022
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX: LABS) (FSE: MLZ) launched CBG and water-soluble products. As of today, these new products will be available in Ontario in both retail stores and on the OCS...
Via
Benzinga
MediPharm Labs Reports Fourth Quarter And Full Year 2021 Results, International Sales Double To $9.5M
↗
March 31, 2022
MediPharm Labs Corp. (OTC: MEDIF) a pharmaceutical company specializing in precision-based cannabinoids, announced on Thursday its financial results for the Fourth Quarter and Full-Year that ended on...
Via
Benzinga
MediPharm Labs Acquires Shelter Cannabis Brands' IP To Expand Portfolio With Flower And Pre-Rolls
↗
March 22, 2022
MediPharm Labs Corp. (OTCQX:MEDIF) (TSXV:
Via
Benzinga
MediPharm Labs Debuts On US Pharmaceutical Market With Submission Of FDA DMF
↗
February 23, 2022
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS
Via
Benzinga
The Canadian Cannabis Report - Monday, Jan. 10
↗
January 10, 2022
The past, present and future of the Canadian cannabis sector based on the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
↗
January 05, 2022
The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI ...
Via
Benzinga
CBD-Focused MediPharm Labs Clears All Of Its $41M Convertible Debt, Reports Strong Cash Position
↗
January 05, 2022
CBD-focused pharmaceutical company MediPharm Labs Corp. (TSXV:) (OTCQX:
Via
Benzinga
The Canadian Cannabis Report - Monday, Jan. 3
↗
January 03, 2022
The past, present, and future of the Canadian cannabis sector based on the MCCCI, which is a proprietary 22 stock index.
Via
Talk Markets
The Canadian Cannabis Report- Monday, Dec. 27
↗
December 27, 2021
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
The Canadian Cannabis Report- Monday, Dec. 20
↗
December 20, 2021
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
Cannabis Movers & Shakers: MediPharm Labs, Kannaway, Affinor Growers, The Weldon Project
↗
December 08, 2021
MediPharm Labs Announces Board Shake-Up CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX:
Via
Benzinga
Topics
Cannabis
The Canadian Cannabis Report - Monday, Dec. 6
↗
December 06, 2021
For the trading week ended December 3, there was a decrease of 12.4% decrease in my proprietary Canadian Cannabis Company Index (MCCCI) compared to the prior week when there was an increase of 1.1%.
Via
Talk Markets
Topics
Cannabis
Avicanna Expands Medical Cannabis Brand RHO Phyto Into Caribbean Region With Export To Barbados
↗
November 25, 2021
Avicanna Inc. (TSX:AVCN) (OTCQX:
Via
Benzinga
Topics
Cannabis
The Canadian Cannabis Report: There Were No Stocks That Increased By More Than 10%
↗
November 23, 2021
The past, present and future performance of the Canadian cannabis sector based on the MCCCI, which is a index of 22 stocks.
Via
Talk Markets
Topics
Cannabis
MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO
↗
November 15, 2021
CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS...
Via
Benzinga
Topics
Cannabis
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
↗
November 19, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021.
Via
Benzinga
Topics
Cannabis
Cannabis Movers & Shakers: Urban-Gro, MediPharm Labs, RWB, Isracann Biosciences, MedMen
↗
October 25, 2021
Former Crop One and Sensei Ag CEO Sonia Lo Joins Urban-Gro’s Board Of Directors Urban-gro, Inc. (NASDAQ:
Via
Benzinga
Topics
Cannabis
MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director
↗
October 21, 2021
MediPharm Labs Corp. (TSX:LABS) (OTCQX:
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.